Dividend FundBack to Nanalyze Dividend
Joe Pivarunas · Founder, Nanalyze · Quantigence dividend growth
Quantigence is Nanalyze’s dividend-growth system. It is available separately, while the broader Nanalyze annual plan also includes technology-stock research and portfolios.
Advertised prices checked on September 21, 2026. Confirm currency, taxes, any offer and the renewal charge with the provider.
Includes the dividend report, Q-Score calculator, international dividend report, monthly newsletter, stock and trade alerts, webinars and access to Joe. The advertised refund window is 30 days.
Adds the tech portfolio with weights, New Money portfolio, tech catalog, research reports and webinars. Annual access includes Quantigence; the tech portfolio is a separate strategy.
Includes research articles, Market Open emails and community access. This tier does not include the portfolio and Quantigence access offered by the annual plan.
The official FAQ describes Quantigence as a 30-stock portfolio in which the team invests its own money. The strategy report explains its selections. This is evidence of a published dividend portfolio, not proof that every current member holding matches an older public video.
There is more public guidance than just the stock list: a 2023 article discusses keeping positions relatively balanced, and a 2024 guide discusses equal monthly purchases with adjustments as holdings diverge. These describe construction methods. They do not disclose the team’s actual September 2026 weights.
Quantigence’s own contact page says its Core, International, Small-Cap and Contenders versions update in January and July. The subscription also advertises a monthly newsletter and trade alerts. Data refresh, portfolio changes and communications are separate schedules; check the latest report alongside subsequent alerts.
Quantigence is the least expensive advertised option focused on dividend growth. The annual Nanalyze bundle is relevant if technology research is also useful. This site’s Q-score estimates and 100-stock research universe are independent of the official paid calculator and portfolio.
The stronger case is for using Quantigence as a portfolio-building research system. Public sources explain much of the process; the current holdings, current weights and a live performance record are different questions.
The team describes seven inputs: dividend history, company size, international sales, five- and ten-year dividend growth, yield and payout ratio. Its calculator lets members inspect factor scores and underlying data, filter sectors and explore Core, International, Small-Cap and Contenders universes. A high score ranks a candidate; it is not proof that the team owns it.
The November 2023 summary discusses systematic quarterly trimming toward relatively equal weights. The November 2024 guide emphasizes monthly purchases and adjusting contributions as positions diverge. Treat these as dated guidance, not evidence of an unchanged current trading rule. A 30-stock equal starting allocation would be about 3.33% each, before cash and rounding; actual weights can drift.
The 2024 guide identifies a failure to keep increasing the dividend as its main exit rule. It also says a lower Q-score does not automatically trigger a sale, using Walmart as a then-current example. Interpreting dividend freezes, corporate actions and replacement choices still involves judgment.
The FAQ says the team does not track strategy performance and points instead to a commissioned study. The linked October 2023 master’s thesis by Livio Luyten and Nicolas Dumont tests portfolio rules; its abstract describes sector selection and quarterly equal-weight rebalancing. That is historical simulation evidence, not an audited record of Joe’s actual account or proof that a subscriber will match it.
Quantigence’s published terms allow limited personal, noncommercial copying and require written permission to reproduce or distribute its content. Subscribing alone should not be treated as permission to republish member tables or calculator data. A public Income Lens replica would need the permitted data-use scope clarified separately.
The public 2024 guide allows flexibility in portfolio size and emphasizes sector diversification. Our 20-name allocation can therefore be an independent application of the philosophy. It cannot be described as the creator’s 30-stock portfolio, and our estimated Q-scores should remain distinct from the official current calculator.
These details were not established by the public sources.
A member can use the report, calculator and alerts to construct a dividend-growth portfolio. An exact copy also needs the team’s current holdings, actual weights and cash. Publishing paid data here raises a separate permission question. A 20-stock adaptation would continue to be an independent Income Lens model.
Public pages, provider FAQs and visible member previews. Research date is not the portfolio’s as-of date. Paid holdings were not accessed.
Advertises $99.99/year, dividend tools, monthly newsletter, alerts and a 30-day refund window.
$299.99/year full access; $19.99/month partial access. Tech weightings are explicitly advertised.
Describes a 30-stock Quantigence portfolio and January/July report updates.
Describes a customizable strategy; does not promise exact current dividend-portfolio weights.
Background on the report’s portfolio selections. Older universe counts are not treated as current holdings.
Historical summary discusses quarterly trimming and keeping positions relatively equal.
Dated guidance on monthly purchases, diversification, dividend-growth failures and discretion around Q-scores.
January/July updates for Core, International, Small-Cap and Contenders versions. No message was sent.
The provider describes its factors, sector selection and investment of its own money.
Features and screening universes are public; the current member data was not accessed.
Master’s thesis, Livio Luyten and Nicolas Dumont. The abstract describes a rules-based historical test; it is not a current holdings list or live account audit.
Section 3 covers personal copying and permission for reproduction or distribution.